文献

J-GLOBAL ID：201702266871268511   整理番号：17A1389307

胸部腫瘍2016における科学的進歩【Powered by NICT】

Scientific Advances in Thoracic Oncology 2016

著者 (46件)： Soo Ross A. (Cancer Science Institute of Singapore, National University of Singapore, Singapore) ,  Soo Ross A. (Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore) ,  Soo Ross A. (School of Surgery, University of Western Australia, Perth, Australia) ,  Stone Emily C.A. (Department of Thoracic Medicine, St. Vincent’s Hospital, Kinghorn Cancer Centre, Sydney, Australia) ,  Cummings K. Michael (Hollings Cancer Center Medical University of South Carolina, Charleston, South Carolina) ,  Jett James R. (National Jewish Health, Denver, Colorado) ,  Field John K. (Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, The University of Liverpool, Liverpool, United Kingdom) ,  Groen Harry J.M. (Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, The Netherlands) ,  Mulshine James L. (Internal Medicine, Graduate College, Rush University Medical Center, Chicago, Illinois) ,  Yatabe Yasushi (Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan) ,  Bubendorf Lukas (Institute of Pathology, University Hospital Basel, Basel, Switzerland) ,  Dacic Sanja (Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania) ,  Rami-Porta Ramon (Department of Thoracic Surgery, Hospital Universitari Mutua Terrassa, University of Barcelona, Network of Biomedical Research Centers in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain) ,  Detterbeck Frank C. (Department of Surgery, Yale University, New Haven, Connecticut) ,  Lim Eric (Academic Division of Thoracic Surgery, The Royal Brompton Hospital and Imperial College, London, United Kingdom) ,  Asamura Hisao (Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan) ,  Donington Jessica (Cardiothoracic Surgery, New York University School of Medicine, New York, New York) ,  Wakelee Heather A. (Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, California) ,  Wu Yi-Long (Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People’s Republic of China) ,  Higgins Kristin (Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia) ,  Senan Suresh (Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands) ,  Solomon Benjamin (Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia) ,  Kim Dong-Wan (Seoul National University Hospital, Seoul, Republic of Korea) ,  Johnson Melissa (Sarah Cannon Research Institute, Nashville, Tennessee) ,  Yang James C.H. (Department of Oncology, National Taiwan University Hospital, Taipei, Republic of China) ,  Sequist Lecia V. (Massachusetts General Hospital, Boston, Massachusetts) ,  Sequist Lecia V. (Harvard Medical School, Boston, Massachusetts) ,  Shaw Alice T. (Massachusetts General Hospital, Boston, Massachusetts) ,  Shaw Alice T. (Harvard Medical School, Boston, Massachusetts) ,  Ahn Myung-Ju (Section of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea) ,  Costa Daniel B. (Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts) ,  Patel Jyoti D. (Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois) ,  Horn Leora (Division of Hematology/Oncology, Vanderbilt Ingram Cancer Center, Nashville, Tennessee) ,  Gettinger Scott (Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut) ,  Peters Solange (Medical Oncology and Thoracic Malignancies, Oncology Department, University Hospital Center Vaudois, Lausanne, Switzerland) ,  Wynes Murry W. (International Association for the Study of Lung Cancer, Aurora, Colorado) ,  Faivre-Finn Corinne (Radiotherapy Related Research, Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital NHS Trust, Manchester, United Kingdom) ,  Rudin Charles M. (Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York) ,  Tsao Anne (Mesothelioma Program, Thoracic Chemo-Radiation Program, Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas) ,  Baas Paul (Department of Chest Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands) ,  Kelly Ronan J. (Deptartment of Medical Oncology, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland) ,  Leighl Natasha B. (Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada) ,  Scagliotti Giorgio V. (San Luigi Hospital, University of Turin, Orbassano, Italy) ,  Gandara David R. (Thoracic Oncology Program, University of California Davis Comprehensive Cancer Center, Sacramento, California) ,  Hirsch Fred R. (Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora) ,  Spigel David R. (Sarah Cannon Research Institute, Nashville, Tennessee)
資料名： Journal of Thoracic Oncology  (Journal of Thoracic Oncology)
巻： 12  号： 8  ページ： 1183-1209  発行年： 2017年 
JST資料番号： W3145A  ISSN： 1556-0864  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： 肺癌ケアはゲノム試験の進歩,次世代標的キナーゼ阻害剤の開発,新しい設定と可能な組合せにおける免疫療法の継続的な広い研究と共に急速に変化した。肺癌の研究とJournalof胸部腫瘍のための国際協会はこの年間更新読者はこれらの重要な開発と歩調を合わせる支援を報告する。胸部癌とケアの専門家は,画像が複数の領域を横切る集束更新,予防と早期発見,分子診断,病理,病期分類,手術,補助療法,放射線療法,分子標的療法,非小細胞肺癌,SCLC,中皮腫のための免疫療法を提供する。肺癌研究と治療の将来に対するケアと展望の品質と値もこの簡潔なレビューに含まれている。Copyright 2017 Elsevier B.V., Amsterdam. All rights reserved. Translated from English into Japanese by JST.【Powered by NICT】

シソーラス用語： ゲノム ,  非小細胞肺癌 ,  早期診断 ,  スクリーニング ,  *胸部腫瘍 ,  中皮腫 ,  免疫療法 ,  放射線療法 ,  画像 ,  肺腫瘍 ,  病理 ,  治療法 ,  分子標的療法
準シソーラス用語： 病期分類 ,  分子診断 , 【Automatic Indexing@JST】

著者キーワード (16件)： NSCLC ,  悪性中皮腫の1例 ,  SCLC ,  禁煙 ,  癌予防 ,  標的療法 ,  免疫療法 ,  スクリーニング ,  病理 ,  病期分類 ,  手術 ,  補助療法 ,  放射線療法 ,  分子診断 ,  バイオマーカー ,  療法の価値

分類 (1件)： 呼吸器の腫よう  (GI04000G)

タイトルに関連する用語 (2件)： 胸部腫瘍 ,  科学